1. Home
  2. TRVI vs AOSL Comparison

TRVI vs AOSL Comparison

Compare TRVI & AOSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • AOSL
  • Stock Information
  • Founded
  • TRVI 2011
  • AOSL 2000
  • Country
  • TRVI United States
  • AOSL United States
  • Employees
  • TRVI N/A
  • AOSL N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • AOSL Semiconductors
  • Sector
  • TRVI Health Care
  • AOSL Technology
  • Exchange
  • TRVI Nasdaq
  • AOSL Nasdaq
  • Market Cap
  • TRVI 725.7M
  • AOSL 616.9M
  • IPO Year
  • TRVI 2019
  • AOSL 2010
  • Fundamental
  • Price
  • TRVI $6.55
  • AOSL $27.68
  • Analyst Decision
  • TRVI Strong Buy
  • AOSL Buy
  • Analyst Count
  • TRVI 9
  • AOSL 3
  • Target Price
  • TRVI $19.94
  • AOSL $28.33
  • AVG Volume (30 Days)
  • TRVI 1.6M
  • AOSL 273.7K
  • Earning Date
  • TRVI 08-07-2025
  • AOSL 08-06-2025
  • Dividend Yield
  • TRVI N/A
  • AOSL N/A
  • EPS Growth
  • TRVI N/A
  • AOSL N/A
  • EPS
  • TRVI N/A
  • AOSL N/A
  • Revenue
  • TRVI N/A
  • AOSL $680,974,000.00
  • Revenue This Year
  • TRVI N/A
  • AOSL $7.05
  • Revenue Next Year
  • TRVI N/A
  • AOSL $2.54
  • P/E Ratio
  • TRVI N/A
  • AOSL N/A
  • Revenue Growth
  • TRVI N/A
  • AOSL 3.57
  • 52 Week Low
  • TRVI $2.36
  • AOSL $15.90
  • 52 Week High
  • TRVI $7.48
  • AOSL $53.29
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 61.06
  • AOSL 63.19
  • Support Level
  • TRVI $5.41
  • AOSL $26.41
  • Resistance Level
  • TRVI $6.08
  • AOSL $28.90
  • Average True Range (ATR)
  • TRVI 0.32
  • AOSL 1.19
  • MACD
  • TRVI 0.09
  • AOSL 0.12
  • Stochastic Oscillator
  • TRVI 96.20
  • AOSL 76.12

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About AOSL Alpha and Omega Semiconductor Limited

Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries.

Share on Social Networks: